FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed.

"As soon as that water’s gone, we don’t have another ice age to re-establish it," a retired hydrologist warns.

Diabetes symptoms typically include increased thirst, urination, and hunger, among other things.